Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice.
about
Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines.Male/Female differences in neuroprotection and neuromodulation of brain dopamineNeurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.Tamoxifen neuroprotection in cerebral ischemia involves attenuation of kinase activation and superoxide production and potentiation of mitochondrial superoxide dismutase.Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.cAMP response element-binding protein (CREB) and nuclear factor κB mediate the tamoxifen-induced up-regulation of glutamate transporter 1 (GLT-1) in rat astrocytesDesign and synthesis of triarylacrylonitrile analogues of tamoxifen with improved binding selectivity to protein kinase C.Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice.Sex differences in methamphetamine-evoked striatal dopamine output are abolished following gonadectomy: comparisons with potassium-evoked output and responses in prepubertal mice.17β-estradiol and tamoxifen protect mice from manganese-induced dopaminergic neurotoxicity.Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice.Sex differences in K+-evoked striatal dopamine output from superfused striatal tissue fragments of reserpine-treated CD-1 mice.
P2860
Q30478476-60100FB1-573B-46EC-8C0A-9F57A3AD9F79Q35972056-FC782E9C-9621-4093-B0F7-E8C691A9EE69Q36102771-80933E21-8BD6-4FF9-AF37-61C7CF5BB2B3Q36372549-3944622D-8DBF-4BF6-A36D-0CEDA85B7065Q36854132-8020A232-8370-4398-AFBA-1C65D1581D7FQ37213877-3A66FCAE-FC92-48A5-B2D8-689935995426Q38744832-62B54221-6AB2-41FA-9CE4-DBA2E7391A77Q44981188-F6087609-3C1E-4604-BA91-AEEFF2809320Q46895969-1762B727-2F6F-40F9-8898-B89C30924798Q47355274-5CA901DB-E10C-4E94-8A70-2FBB44CF38EBQ48439931-6012A281-2F55-4B4B-8BDE-66D4240AC8BAQ51743205-A57FFE12-0EC7-42E8-B605-2AB45EE131AA
P2860
Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Tamoxifen diminishes methamphe ...... n intact female and male mice.
@en
Tamoxifen diminishes methamphe ...... n intact female and male mice.
@nl
type
label
Tamoxifen diminishes methamphe ...... n intact female and male mice.
@en
Tamoxifen diminishes methamphe ...... n intact female and male mice.
@nl
prefLabel
Tamoxifen diminishes methamphe ...... n intact female and male mice.
@en
Tamoxifen diminishes methamphe ...... n intact female and male mice.
@nl
P2093
P2860
P1476
Tamoxifen diminishes methamphe ...... n intact female and male mice.
@en
P2093
Anderson LI
McDermott JL
P2860
P304
P356
10.1046/J.1365-2826.2001.00675.X
P577
2001-07-01T00:00:00Z